NCT07472582

Brief Summary

The goal of this clinical trial is to investigate whether receiving chatbot-delivered stage-of-change-tailored online interventions is effective in reducing chemsex among men who have sex with men in Hong Kong. The main question it aims to answer is: Does chatbot-delivered stage-of-changed online interventions reduce chemsex among men who have sex with men Eligible participants will be randomly assigned to either the intervention or the control group. The control group will watch one online video introducing chemsex-related knowledge and harm reduction skills per week for 12 weeks. On top of the interventions received by the control group, participants in the intervention group will have access to a chatbot during the 12-week intervention period. The chatbot will deliver 12 weekly episodes of interventions tailored to once's current stage-of-change related to chemsex. The chatbot will also address questions related to chemsex during the intervention period.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
9mo left

Started Apr 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Apr 2026Mar 2027

First Submitted

Initial submission to the registry

February 11, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 16, 2026

Completed
16 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

12 months

First QC Date

February 11, 2026

Last Update Submit

March 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence of chemsex in the past 3 months

    Presence of chemsex will be measured by a validated questionnaire. Chemsex is defined as the use of any of the following psychoactive substances before or during sexual intercourse: ketamine, methamphetamine, cocaine, cannabis, ecstasy, Dormicum/Halcion/Erimin 5/nonprescription hypnotic drugs, heroin, cough suppressant (not for curing cough), amyl nitrite (popper), GHB/GBL, 5-methoxy-N, N-diisopropyltryptamine (Foxy), and mephedrone. Participants will be asked whether they had used any of the aforementioned psychoactive substances before or during sexual intercourse in the past 3 months at baseline, after completion of the 12-week intervention (Month 3 or Week 12), and 3 months after completion of the 12-week intervention (Month 6)

    Baseline, after completion of the 12-week intervention (Month 3 or Week 12), and 3 months after completion of the 12-week intervention (Month 6)

Study Arms (2)

Intervention group

EXPERIMENTAL

Chatbot-delivered interventions and online videos

Behavioral: Chatbot-delivered online interventions and online videos

Control group

ACTIVE COMPARATOR

Online videos only

Behavioral: Online videos only

Interventions

Participants will watch one online video introducing chemsex-related knowledge and harm reduction skills per week for 12 weeks. The chatbot will deliver 12 weekly episodes of interventions tailored to once's current stage-of-change related to chemsex. The chatbot will also address questions related to chemsex during the intervention period.

Intervention group

Participants will watch one online video introducing chemsex-related knowledge and harm reduction skills per week for 12 weeks.

Control group

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hong Kong men aged at least 18 years
  • Able to understand Cantonese
  • Had anal intercourse with at least one man within the past six months
  • Willingness to provide contact information for follow-up
  • Having access to WhatsApp

You may not qualify if:

  • Self-reported a diagnosis of schizophrenia or bipolar disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Behavior

Central Study Contacts

Zixin Wang, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 11, 2026

First Posted

March 16, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

March 31, 2027

Last Updated

March 16, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

The data contains sensitive behaviors.